| Literature DB >> 11228833 |
Abstract
Passerines (songbirds) and softbills (toucans and mynahs) are increasingly presented for veterinary care as pet owners and aviculturists recognize that successful medical and surgical treatment can be performed in these often tiny patients. Even with an increasing amount of pharmacokinetic data in birds, the use of extrapolated drug regimens continues to be a common practice for these species. The extrapolation, using allometric scaling from human, mammalian, and avian drugs to passeriformes and softbills, is complicated and limited. In this article, the choice of the therapeutic approach is discussed. Once the choice for a specific drug is made, tables help calculate the dose in milligrams per kilocalorie without using complicated formulas.Entities:
Mesh:
Substances:
Year: 2000 PMID: 11228833 PMCID: PMC7110521 DOI: 10.1016/s1094-9194(17)30094-4
Source DB: PubMed Journal: Vet Clin North Am Exot Anim Pract ISSN: 1094-9194
Conversion of Body Weight (g) to Basal Metabolism (kcal) for Passerines (Pass) and Nonpasserines (N-pass)
| BW (g) | Pass | N-pass | BW (g) | Pass | N-pass | BW (g) | Pass | N-pass |
|---|---|---|---|---|---|---|---|---|
| 10 | 4 | 2 | 155 | 32 | 19 | 480 | 74 | 45 |
| 11 | 4 | 3 | 160 | 33 | 20 | 490 | 76 | 46 |
| 12 | 5 | 3 | 165 | 33 | 20 | 500 | 77 | 46 |
| 13 | 5 | 3 | 170 | 34 | 21 | 520 | 79 | 48 |
| 14 | 5 | 3 | 175 | 35 | 21 | 540 | 81 | 49 |
| 15 | 6 | 3 | 180 | 36 | 22 | 560 | 84 | 50 |
| 16 | 6 | 4 | 185 | 36 | 22 | 580 | 86 | 52 |
| 17 | 6 | 4 | 190 | 37 | 22 | 600 | 88 | 53 |
| 18 | 6 | 4 | 195 | 38 | 23 | 620 | 90 | 54 |
| 19 | 7 | 4 | 200 | 39 | 23 | 640 | 92 | 56 |
| 20 | 7 | 4 | 210 | 40 | 24 | 660 | 94 | 57 |
| 25 | 8 | 5 | 220 | 41 | 25 | 680 | 97 | 58 |
| 30 | 9 | 6 | 230 | 43 | 26 | 700 | 99 | 60 |
| 35 | 10 | 6 | 240 | 44 | 27 | 720 | 101 | 61 |
| 40 | 12 | 7 | 250 | 46 | 28 | 740 | 103 | 62 |
| 45 | 13 | 8 | 260 | 47 | 28 | 760 | 105 | 63 |
| 50 | 14 | 8 | 270 | 48 | 29 | 780 | 107 | 65 |
| 55 | 15 | 9 | 280 | 50 | 30 | 800 | 109 | 66 |
| 60 | 16 | 9 | 290 | 51 | 31 | 820 | 111 | 67 |
| 65 | 17 | 10 | 300 | 52 | 32 | 840 | 113 | 68 |
| 70 | 18 | 11 | 310 | 54 | 32 | 860 | 115 | 70 |
| 75 | 18 | 11 | 320 | 55 | 33 | 880 | 117 | 71 |
| 80 | 19 | 12 | 330 | 56 | 34 | 900 | 119 | 72 |
| 85 | 20 | 12 | 340 | 57 | 35 | 920 | 121 | 73 |
| 90 | 21 | 13 | 350 | 59 | 35 | 940 | 123 | 74 |
| 95 | 22 | 13 | 360 | 60 | 36 | 960 | 125 | 76 |
| 100 | 23 | 14 | 370 | 61 | 37 | 980 | 127 | 77 |
| 105 | 24 | 14 | 380 | 62 | 38 | 1000 | 129 | 78 |
| 110 | 25 | 15 | 390 | 64 | 38 | 1020 | 131 | 79 |
| 115 | 25 | 15 | 400 | 65 | 39 | 1040 | 133 | 80 |
| 120 | 26 | 16 | 410 | 66 | 40 | 1060 | 135 | 81 |
| 125 | 27 | 16 | 420 | 67 | 41 | 1080 | 137 | 83 |
| 130 | 28 | 17 | 430 | 69 | 41 | 1100 | 139 | 84 |
| 135 | 29 | 17 | 440 | 70 | 42 | 1120 | 140 | 85 |
| 140 | 30 | 18 | 450 | 71 | 43 | 1140 | 142 | 86 |
| 145 | 30 | 18 | 460 | 72 | 44 | 1160 | 144 | 87 |
| 150 | 31 | 19 | 470 | 73 | 44 | 1180 | 146 | 88 |
Conventional Dosage Regimens for Antimicrobial Drugs in Pet Birds
| Routes | Dose (mg/kcal) | Dose (mg/kg) | Interval (hr) | Remarks | |
|---|---|---|---|---|---|
| Cloxacillin | IM | 2.16 4.31 | 100 200 | 24 | |
| Ampicillin–Na | IM | 3.50 | 150 | 12–24 | Gram–positives |
| Ampicillin–trihydrate | PO | 0.58 | 25 | 12–24 | Gram–positives |
| PO | 2.80 4.08 | 120 175 | 12–24 | Gram–negatives | |
| Amoxycillin–Na | IM | 1.17 | 50 | 12–24 | Gram–positives |
| 5.83 | 250 | 12–24 | Gram–negatives | ||
| Amoxycillin–trihydrate | PO | 0.47 | 20 | 12–24 | Gram–positives |
| PO | 2.55 4.46 | 100 175 | 12–24 | Gram–negatives | |
| AX.–long–acting | IM | 2.33 | 100 | 48 | Gram–positives |
| Amoxycillin/clavulanic acid (1) | IM | 1.17 | 50 | 8–12 | Gram–positives |
| PO | 2.33 | 100 | 8–12 | Gram–positives | |
| IM | 2.33 | 100 | 8–12 | Gram–negatives | |
| PO | 4.67 | 200 | 8–12 | Gram–negatives | |
| PO | 1.17 2.33 | 50 100 | 12 | Intestinal infections | |
| Carbenicillin | IM | 2.55 5.10 | 100 200 | 8–12 | Synergistic with aminoglycosides |
| IV | 2.55 5.10 | 100 200 | 8–12 | ||
| IT | 2.55 | 100 | 24 | ||
| Ticarcillin | IM, IV | 3.82 5.10 | 150 200 | 2–4 | Synergistic with aminoglycosides |
| Cefotaxime | IM, IV | 1.62 2.16 | 75 100 | 6–8 | |
| Cefoxitin | IM, IV | 1.08 1.62 | 50 75 | 6–8 | |
| Ceftrioxone | IM, IV | 1.62 2.16 | 75 100 | 4–6 | |
| Ceftazidine | IM, IV | 1.62 2.16 | 75 100 | 6–8 | |
| Ceftiofur | IM | 1.08 2.16 | 50 100 | 6 | |
| Cephalothin | IM, IV | 2.16 | 100 | 2–6 | |
| Cephalexin monohydrate | PO | 1.08 2.16 | 50 100 | 8 | |
| 0.16 0.23 | 35 50 | 2–6 | |||
| Cephradine | PO | 0.75 1.08 | 35 50 | 6 | |
| Piperacillin | IM, IV | 4.31 | 200 | 6–8 | Synergistic with aminoglycosides |
| 1.91 2.55 | 75 100 | 4–6 | |||
| Polymixin B | PO | 1078.07 | 50000 | 12 | |
| Neomycin | PO | 0.22 | 10 | 24 | |
| Streptomycin | PO | 0.64 1.28 | 50 100 | 24 | |
| PO | 2.33 4.67 | 100 200 | 24 | ||
| IM | 0.22 0.65 | 10 30 | 8–12 | ||
| Kanamycin | IM | 0.22 0.43 | 10 20 | 12 | |
| Gentamycin | IM | 0.05 0.22 | 3 10 | 6–12 | Nephrotoxicity |
| PO | 1.02 | 40 | 8–24 | Intestinal tract infections | |
| Amikacin | IM, IV | 0.38 0.51 | 15 20 | 8–12 | Nephrotoxicity |
| 0.51 1.02 | 20 40 | 12–24 | |||
| Tobramycin | IM, IV | 0.05 0.11 | 35 | 12 | |
| Spectinomycin | IM, SC | 0.58 | 25 | 8 | |
| PO | 0.65 | 30 | 24 | ||
| PO | 1.92 3.21 | 150 250 | 24 | Flock treatment enteritis | |
| Lincomycin | PO | 0.82 1.17 | 35 50 | 12–24 | Overdose caused death |
| Lincomycin/spectinomycin | PO | 1.08 | 50 | 24 | |
| Clindamycin | PO | 2.33 | 100 | 24 | |
| Erythromycin | IM | 0.23 0.47 | 10 20 | 24 | |
| PO | 1.17 2.33 | 50 100 | 8–12 | ||
| Spiramycin | IM | 0.58 | 25 | 24 | |
| PO | 1.08 | 50 | 24 | ||
| Tylosin | IM | 0.22 0.86 | 10 40 | 6–8 | |
| PO | 1.08 | 50 | 24 | ||
| Tiamulin | PO | 0.54 1.08 | 25 50 | 24 | |
| Oleandomycin | IM | 0.58 | 25 | 24 | |
| PO | 1.17 | 50 | 24 | ||
| Chloramph–succinate | IM | 2.33 | 100 | 6 | |
| 1.27 | 50 | 8–12 | |||
| 1.08 1.72 | 50 80 | 12–24 | |||
| Chloramph–palmitate | PO | 1.27 2.55 | 50 100 | 6–12 | |
| Chlortetracyclin | PO | 0.93 1.17 | 40 50 | 8 | Grit |
| PO | 0.93 1.17 | 40 50 | 12 | No grit | |
| Diet | 0.25–1.0% | 45 days | |||
| Oxytetracyclin | IM, SC | 0.32 1.08 | 15 50 | 12–24 | Tissue damage |
| OTC long-acting | IM, SC | 1.27 2.55 | 50 100 | 48–72 | |
| Tetracyclin | PO | 1.27 | 50 | 8 | |
| Doxycyclin | PO | 0.58 | 25 | 12 | Grit |
| PO | 0.18 | 8 | 12 | No grit | |
| Doxycyclin | |||||
| (Vibramycin-IV) | IM, SC | 1.75 2.33 | 75 100 | 5–7 days | |
| Trimethoprim (T) | PO | 0.35 0.47 | 15 20 | 8 | |
| T + sulfatroxazole | PO | 0.23 1.17 | 10 50 | 12 | |
| T + sulfamethoxazole | PO | 0.23 1.17 | 10 50 | 24 | |
| Flumequine | IM, PO | 0.70 | 30 | 8–12 | Vomiting! |
| Ciprofloxacin | PO, IM | 0.32 0.43 | 15 20 | 12 | |
| Enrofloxacin | IM, SC | 0.12 0.23 | 5 10 | 24 | |
| PO | 0.23 0.47 | 10 20 | 12–24 | ||
| Food | 250 1000 | 24 | |||
| Furazolidone | PO | 0.35 0.47 | 15 20 | 24 | |
| Furaltadone | PO | 0.35 0.47 | 15 20 | 24 | |
| Isoniazid | PO | 0.11 0.32 | 5 15 | 12 | GI and CNS disorder |
| Rifampin | PO | 0.22 0.43 | 10 20 | 12–24 | |
| Rifabutin | PO | 0.38 1.15 | 15 45 | 24 | |
| Ethambutol | PO | 0.32 0.65 | 15 30 | 12–24 | For combination treatment |
| Streptomycin | PO | 0.51 1.02 | 20 40 | 24 | |
| Amikacin | IM | 0.38 0.76 | 15 30 | 12–24 | |
| Ciprofloxacin/enrofloxacin | PO | 0.38 0.76 | 15 30 | 12–24 | |
| Clofazamine | PO | 0.15 0.31 | 6 12 | 24 | |
| Clarithromycin | PO | 1.83 | 85 | 24 | |
| Azithromycin | PO | 0.97 | 45 | 24 | |
| 5-flucytosine | PO | 0.76 1.27 | 30 50 | 6–12 | icw amphoteracin B 14–28 days |
| Amphoteracin B | IV | 0.03 | 2 | 8–12 | 5–7 days |
| Amphoteracin B | IT | 0.02 | 1 | 8–12 | |
| Amphoteracin B | PO | 0.11 | 5 | 24 | |
| Caprillic acid | PO | 5.39 | 250 | 24 | |
| Chlorhexidine | PO | 0.11 0.22 | 5 10 | 24 | Toxic for finches |
| Enilconazole | Aerosol | — | — | Only disinfection equipment | |
| Fluconazole | PO | 0.04 0.11 | 25 | 24 | 7–10 days |
| Griseofulvine | PO | 0.26 | 20 | 24 | 4–6 wk, dermatomycosis |
| Itraconazole | PO | 0.13 0.25 | 5 10 | 12–24 | 14 days, in orange juice or 0.1 N HCl |
| Ketoconazole | PO | 0.51 0.76 | 20 30 | 12 | 14–30 days ?liver damage? |
| Miconazole | IM, IV | 0.22 0.43 | 10 20 | 8–24 | Candida or cryptococcus infection |
| Nystatin | PO | 2549 7647 | 100,000 300,000 | 8–12 | 7–10 days |
| Ronidazol | PO | 0.4 | 31.2 | Against flagellates | |
| Toltrazuril | PO | 0.09 | 7.02 | Coccidiostatic | |
| Deferoxamine | IM | 1.28 | 100 | 24 | Iron chelator used in toucans |
| Insulin | IM | 0.006 0.013 | 0.5 1.0 | 24 | |
| Chloroquine | PO | 0.216 0.539 | 10 25 | 24 | Bloodparasites, see specific protocol |
| Clazuril | PO | 0.108 0.216 | 5 10 | 24 | Coccidiostatic |
| Dimetridazole | PO | 0.065 | 3 | 24 | Against flagellates |
| Fenbendazole | PO | 0.032 | 2 | 24 | Anthelmintic |
| Ivermectin | IM, PO | 0.004 | 0.2 | 6 wk | Anthelmintic |
| Levamisole | PO | 0.043 | 2 | 24 | Anthelmintic |
| Metronidazole | PO | 0.108 | 5 | 24 | Against flagellates |
| Oxfenbendazole | PO | 0.862 | 40 | 24 | Anthelmintic |
| Praziquantel | PO | 0.270 0.539 | 13 25 | 24 | Anthelmintic (trematodes and cestodes) |
| Pyrimethamine | PO | 0.011 0.022 | 1 2 | 24 | Blood parasites, see specific protocol |
| Ronidazol | PO | 0.323 | 15 | 24 | Against flagellates |
| Toltrazuril | PO | 0.090 | 7 | 24 | Coccidiostatic |
For the calculation of the metabolic dosage, the following body weights were used when pharmacokinetic studies were available: pigeon 450 g, parrot 400 g. Conversion from mg/kg to mg/kcal = dose/(KW0 75).
Adapted from Dorrestein GM: Antimicrobial drug use in pet birds. In Prescott JF, Baggot JD (eds): Antimicrobial Therapy in Veterinary Medicine. Ames, IA, Iowa State University Press, 1993, p 490; with permission.
Dosage Regimens for Chemotherapeutic, Antibiotic, and Other Agents Used in Drinking Water in Birds
| Drug | Metabolic Dose (mg/kcal) | Calculated Water Cone (mg/L) | BW (g) | Passerine K = 129 (kcal/day) | Non-passerine K = 78 (kcal/day) |
|---|---|---|---|---|---|
| Amoxycillin (low level) | 0.47 | 940 | 10 | 4 | 2 |
| Amoxycillin (high level) | 2.55 | 5100 | 20 | 7 | 2 |
| Amoxycillin/clav. acid | 4.31 | 8620 | 30 | 9 | 6 |
| Ampicillin (low level) | 0.58 | 1160 | 40 | 12 | 7 |
| Ampicillin (high level) | 2.80 | 5600 | 50 | 14 | 8 |
| Chloroquine | 0.22 | 431 | |||
| Chlortetracycline (low level) | 0.93 | 1860 | 60 | 16 | 9 |
| Chlortetracycline (high level) | 1.17 | 2340 | 70 | 18 | 11 |
| Dimetridazole | 0.06 | 129 | 80 | 19 | 12 |
| Doxycycline with grit | 0.58 | 1160 | 90 | 21 | 13 |
| Doxycycline without grit | 0.18 | 360 | 100 | 23 | 14 |
| Enrofloxacin | 0.23 | 460 | |||
| Erythromycin | 1.17 | 2340 | 150 | 31 | 19 |
| Fenbendazole | 0.03 | 50 | 200 | 39 | 23 |
| Furazolidone | 0.35 | 700 | 250 | 46 | 28 |
| Ivermectin | 0.004 | 9 | 300 | 52 | 32 |
| Levamisole | 0.04 | 80 | 350 | 59 | 35 |
| Lincomycin | 0.82 | 1633 | |||
| Lincospectine | 1.08 | 2156 | 400 | 65 | 39 |
| Ketoconazole | 0.51 | 1020 | 450 | 71 | 43 |
| Metronidazole | 0.11 | 216 | 500 | 77 | 46 |
| Neomycin | 0.22 | 440 | 550 | 82 | 50 |
| Nystatin (IU) | 2549 | 5,097,889 | 600 | 88 | 53 |
| Polymyxin (IU) | 1078 | 2,156,145 | |||
| Ronidazol | 0.32 | 647 | 650 | 93 | 56 |
| Spectinomycin | 0.65 | 1300 | 700 | 99 | 60 |
| Spiramycin | 1.08 | 2156 | 750 | 104 | 63 |
| Sulphachlor-pyrazin | 0.07 | 140 | 800 | 109 | 66 |
| Sulphadimidine | 0.07 | 140 | 850 | 114 | 69 |
| Toltrazuril | 0.09 | 180 | 900 | 119 | 72 |
| Trim/sulpha | 0.23 | 460 | 950 | 124 | 75 |
| Tylosin | 0.38 | 760 | 1000 | 129 | 78 |
Based on the dosage in mg/kcal (BMR = KW0 75) and a water intake of 0.5 mg/kcal. The calculated dose should preferably be divided over water and food.
Calculated for amoxycillin part only.
In case of ornithosis for 30 days.
Metabolic dose estimated from drinking water concentration.
In case of ornithosis for 21 days.
For the treatment of Candida albicans for 3 to 6 wk.
This dosage is for the trimethoprim part alone.
Tests, Problems, and Available Pharmacologic Intervention
| Digestive problems without a high mortality rate: | Agent |
|---|---|
| In a stained cloacal smear: | |
| Bacteria (rods or cocci) | Neomycin |
| Campylobacter | Doxycy cline |
| Yeasts | Amphotericin B |
| Flagellates | Ronidazole/metronidazole |
| In a wet mount: | |
| Flagellates | Ronidazole/metronidazole |
| Coccidia | Sulfachlorpyrazine/amprolium |
| Nematodes | Levamisole/ivermectin |
| Trematodes | Praziquantel |
| In the direct smear (feces and/or necropsy) | |
| Cocci | Amoxycillin/clavulanic acid |
| Gram-negative rods | Trimethoprim-sulfamethoxazole |
| Yeasts | Amphotericin B |
| Doxycyclin |